Harvard Bioscience spin-off is stepping up its production of synthetic tracheas to supply clinical trials.
By delivering gene therapies to patients before they go blind, doctors may be able to prevent the loss of many important light-detecting cells.
Illumina announces a new high-end sequencer made for “factory-scale” sequencing of human genomes.
A paralyzed man will receive experimental surgery connecting a brain chip to systems that activate muscles in his arm.
A former hockey player founded a company to give athletes and families a better way to identify brain injuries.
The ability to print retinal cells could lead to new therapies for retinal disorders such as macular degeneration.
New method could help scientists understand neural circuits and tumor biology.
A new surgical adhesive is strong enough, and elastic enough, to seal a beating heart.
A novel vaccine design could lead to new weapons against often deadly bacterial infections.
Following the Supreme Court's rejection of gene patents, the U.S. proposes steep cuts to reimbursements for tests that detect breast cancer genes.